Find any stock by ticker or company name
All rights reserved.
0.00
0.00 (0.00%)
Company Begins Executing Revenue Generation Strategy through First Commercial Product Launch New York, NY – Aug. 11, 2026 – TheNewswire – Synbio International, Inc. (OTC: SYIN) today marks a significant milestone in its evolution. After an extended period focused on corporate restructuring, strategic partnerships, and business development, the Company is now entering commercial operations with the launch of its Healing Force™ nutraceutical division and first consumer product.
There is no data to display